Risk factor
Very high price volatility
Profitability factor
Strong margins and returns
About
WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the People's Republic of China, North America, Europe, and internationally. The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing...
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. In particular, the stock is reasonably priced on P/E, of fair
Target Price
The average target price of 2269.HK is 39 and suggests 24% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre
Buy
Sell